Lv2
190 积分 2023-10-11 加入
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study
3个月前
已完结
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study
3个月前
已完结
Genetic contributions to NAFLD: leveraging shared genetics to uncover systems biology
8个月前
已完结
Natural history and progression of metabolic dysfunction-associated steatotic liver disease
8个月前
已完结